According to a small 2021 study, sleep apnea tests in a lab are the gold standard, but home sleep apnea tests may compare well to lab tests. The study involved 40 people and compared lab testing ...

The Pros and Cons of Home Sleep Apnea Testing . There are certain obvious benefits to having a home sleep apnea test. One of the biggest attractions is the greater convenience of being able to sleep ...

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea. | The NightOwl, about the size of a quarter, is worn on the user’s ...

Continuous Positive Airway Pressure (CPAP) machines are used to keep the airways open while someone sleeps. It's the gold ...

SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced its ...

(RTTNews) - ResMed Inc.(RMD), announced Thursday that its NightOwl home sleep apnea test or HSAT is now available across the United States, providing a simple and effective at-home diagnostic ...

NEWARK, Del, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The Home Sleep Apnea Testing Market is poised for significant expansion from USD 712.3 million in 2025 to a projected USD 966.1 million by 2035 ...

Sleep apnea affects nearly 39 million people in the United States, with many more potentially undiagnosed due to the traditional requirement of a clinical sleep study. At-home sleep tests look for ...

Sleep apnea home testing ... to pick up and return the equipment. Either way, sleep professionals such as physiologists or consultants have to spend up to two hours interpreting each set of results to ...

FDA-cleared home sleep test provides an effective and simplified solution to obstructive sleep apnea testing and diagnosisSAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD ...

FDA-cleared home sleep test provides an effective and simplified solution to obstructive sleep apnea testing and diagnosis. SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), ...